Table 2 Baseline data comparison between single- and multiple-injection groups
All Patients n = 29 | Single-injection n = 13 (44.83%) | Multiple-injection n = 16 (55.17%) | P1 | |
|---|---|---|---|---|
Age (in years) | 58.59 ± 13.27 | 51.08 ± 13.41 | 64.69 ± 9.82 | *0.003 |
Gender | ||||
Female | 13 (44.83%) | 4 (30.77%) | 9 (56.25%) | 0.264 |
Male | 16 (55.17%) | 9 (69.23%) | 7 (43.75%) | |
DM | 12 (41.38%) | 2 (15.38%) | 10 (62.50%) | *0.021 |
Hypertension | 16 (55.17%) | 7 (53.85%) | 9 (56.25%) | 1.000 |
BCVA (Letters) | 40.93 ± 31.41 | 47.69 ± 31.78 | 35.44 ± 31.01 | 0.300 |
CRT (in μm) | 457.8 ± 167.1 | 391.2 ± 135.0 | 511.9 ± 174.9 | 0.051 |
IOP (in mmHg) | 15.31 ± 3.31 | 15.31 ± 2.95 | 15.31 ± 3.66 | 0.990 |
Lens Status | ||||
Phakic | 19 (65.52%) | 11 (84.62%) | 8 (50.00%) | 0.114 |
Pseudophakic | 10 (34.48%) | 2 (15.38%) | 8 (50.00%) | |